• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由大环内酯类耐药肺炎支原体引起的成人社区获得性肺炎。

Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.

机构信息

Inoue Hospital, Nagasaki 850-0045, Japan.

出版信息

Respirology. 2009 Nov;14(8):1206-8. doi: 10.1111/j.1440-1843.2009.01619.x. Epub 2009 Sep 1.

DOI:10.1111/j.1440-1843.2009.01619.x
PMID:19732389
Abstract

A 28-year-old woman with community-acquired pneumonia was treated with sulbactam/ampicillin and clarithromycin, but failed to show any improvement after 4 days. The antibiotic regimen was changed to pazufloxacin and rapid clinical improvement was seen. Mycoplasma pneumoniae was identified as the causative agent, and adenine (A) to guanine (G) mutation at position 2063 in domain V of the 23S rRNA was noted in the isolate. The minimum inhibitory concentration of macrolide antibiotics, including clarithromycin, of this isolate was greatly elevated.

摘要

一位 28 岁女性因社区获得性肺炎接受了舒巴坦/氨苄西林和克拉霉素治疗,但 4 天后未见明显改善。抗生素方案改为帕珠沙星,临床迅速改善。鉴定出病原体为肺炎支原体,分离株中 23S rRNA 结构域 V 第 2063 位腺嘌呤(A)到鸟嘌呤(G)突变。该分离株对包括克拉霉素在内的大环内酯类抗生素的最小抑菌浓度显著升高。

相似文献

1
Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.由大环内酯类耐药肺炎支原体引起的成人社区获得性肺炎。
Respirology. 2009 Nov;14(8):1206-8. doi: 10.1111/j.1440-1843.2009.01619.x. Epub 2009 Sep 1.
2
Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.6 岁男孩患耐大环内酯类肺炎支原体所致重症社区获得性肺炎。
Hong Kong Med J. 2011 Oct;17(5):407-9.
3
Chlamydia pneumoniae and Mycoplasma pneumoniae.肺炎衣原体和肺炎支原体。
Semin Respir Crit Care Med. 2005 Dec;26(6):617-24. doi: 10.1055/s-2005-925525.
4
Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.成人社区获得性肺炎中对大环内酯类耐药的肺炎支原体
Int J Antimicrob Agents. 2010 Oct;36(4):384-5. doi: 10.1016/j.ijantimicag.2010.06.009. Epub 2010 Jul 31.
5
Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.多西环素治疗儿童大环内酯类耐药肺炎支原体相关社区获得性肺炎后的快速退热
Pediatr Infect Dis J. 2013 Dec;32(12):1396-9. doi: 10.1097/INF.0b013e3182a25c71.
6
Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.成人社区获得性肺炎住院患者中“非典型病原体”的作用。
Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5.
7
Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.儿童肺炎支原体新出现的大环内酯类耐药性:耐药菌株的检测与特征分析
Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.
8
Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.大环内酯类抗生素治疗儿童肺炎支原体肺炎中基因决定的大环内酯类耐药的临床疗效。
Respirology. 2012 Feb;17(2):354-62. doi: 10.1111/j.1440-1843.2011.02102.x.
9
Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.2009 年日本山形县爆发的大环内酯类耐药肺炎支原体社区感染。
Pediatr Infect Dis J. 2013 Mar;32(3):237-40. doi: 10.1097/INF.0b013e31827aa7bd.
10
[Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].[中国北京成年社区获得性肺炎患者肺炎支原体大环内酯类耐药性调查]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Dec;36(12):954-8.

引用本文的文献

1
Mycoplasma pneumoniae from the Respiratory Tract and Beyond.来自呼吸道及其他部位的肺炎支原体
Clin Microbiol Rev. 2017 Jul;30(3):747-809. doi: 10.1128/CMR.00114-16.
2
Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.免疫功能正常患者耐碳青霉烯类肺炎克雷伯菌感染的危险因素
Curr Infect Dis Rep. 2017 Mar;19(3):11. doi: 10.1007/s11908-017-0565-x.
3
Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.日本肺炎支原体感染的流行病学及大环内酯类耐药肺炎支原体的治疗策略
Front Microbiol. 2016 May 23;7:693. doi: 10.3389/fmicb.2016.00693. eCollection 2016.
4
Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae.住院儿童感染大环内酯类耐药肺炎支原体的特征。
Braz J Infect Dis. 2014 May-Jun;18(3):294-9. doi: 10.1016/j.bjid.2013.09.004. Epub 2014 Jan 3.
5
Macrolide resistance of Mycoplasma pneumoniae and its detection rate by real-time PCR in primary and tertiary care hospitals.大环内酯类耐药的肺炎支原体及其在基层和三级医院实时 PCR 检测率。
Ann Lab Med. 2013 Nov;33(6):410-4. doi: 10.3343/alm.2013.33.6.410. Epub 2013 Oct 17.
6
Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.肺炎支原体 23S rRNA 基因突变频率在儿童和成人社区获得性肺炎中的差异:突变赋予大环内酯类耐药的临床影响。
Antimicrob Agents Chemother. 2012 Dec;56(12):6393-6. doi: 10.1128/AAC.01421-12. Epub 2012 Sep 24.
7
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.青少年社区获得性肺炎中耐大环内酯类肺炎支原体。
BMC Infect Dis. 2012 May 31;12:126. doi: 10.1186/1471-2334-12-126.
8
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.以色列 2010 年肺炎支原体大环内酯类耐药性。
Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.